The epidermal barrier has surprising functional redundancy that can compensate for loss of single protein components including loricrin or involucrin,54 and the NKO do not show any sign of flakyness, itching, or increased susceptibility to skin infections as would be expected with a barrier defect. This evidence concerns the gene LORICRIN and skin infection.